BOWER MOUNT MEDICAL PRACTICE — All Prescriptions & Medications — Page 11
Practice Code: G82031 | MAIDSTONE, ME16 8AX
Showing results 501-550 of 607
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| RtS 1.5 - 1.6 kcal/ml milkshake higher protein (0913011) | 16 | 121.0K | £1.3K | -14.5% ▼ |
| Ready to serve 1.5 kcal/ml milkshake with fibre (0913021) | 16 | 168.0K | £4.4K | +15.9% ▲ |
| Diclofenac sodium | 16 | 578 | £151 | -68.5% ▼ |
| Betamethasone sodium phosphate | 16 | 160 | £35 | -38.2% ▼ |
| 16 | 330 | £361 | -59.4% ▼ | |
| 16 | 125 | £214 | -3.0% ▼ | |
| 16 | 2,450 | £211 | -60.9% ▼ | |
| Glyceryl trinitrate | 15 | 450 | £560 | +12.9% ▲ |
| Guanfacine | 15 | 532 | £1.0K | -41.6% ▼ |
| Orlistat | 15 | 1,344 | £316 | -81.8% ▼ |
| Aspirin | 15 | 1,338 | £109 | +52.6% ▲ |
| Minocycline hydrochloride | 15 | 504 | £246 | +164.2% ▲ |
| Dapsone | 15 | 756 | £180 | +45.2% ▲ |
| Betamethasone sodium phosphate | 15 | 1,352 | £178 | +22.0% ▲ |
| Medroxyprogesterone acetate | 15 | 1,159 | £204 | -60.8% ▼ |
| Cabergoline | 15 | 136 | £309 | -3.3% ▼ |
| Powder 2.3 - 2.4 kcal/ml milkshake lower volume (0913011) | 15 | 637 | £333 | -41.6% ▼ |
| Tafluprost | 15 | 480 | £195 | -19.1% ▼ |
| Pimecrolimus | 15 | 480 | £298 | -11.4% ▼ |
| Azelaic acid | 15 | 780 | £165 | -37.3% ▼ |
| 15 | 15 | £1.9K | -58.0% ▼ | |
| 15 | 1,080 | £505 | +20.2% ▲ | |
| Methyldopa | 14 | 784 | £191 | -17.8% ▼ |
| Haloperidol | 14 | 140 | £740 | -70.6% ▼ |
| Zuclopenthixol hydrochloride | 14 | 1,400 | £107 | -55.6% ▼ |
| Paracetamol combined preparations | 14 | 1,356 | £267 | +85.2% ▲ |
| Clonidine hydrochloride | 14 | 2,688 | £264 | -73.8% ▼ |
| Acarbose | 14 | 392 | £108 | +19.9% ▲ |
| Tibolone | 14 | 728 | £67 | -54.3% ▼ |
| Potassium chloride | 14 | 540 | £54 | -25.1% ▼ |
| Dexamethasone sodium metasulphobenzoate | 14 | 112 | £100 | +88.4% ▲ |
| Ketoconazole | 14 | 690 | £93 | +40.7% ▲ |
| 14 | 237 | £232 | -56.7% ▼ | |
| 14 | 227 | £125 | -62.2% ▼ | |
| 14 | 454 | £2.4K | +62.8% ▲ | |
| 14 | 145 | £317 | -49.7% ▼ | |
| 14 | 460 | £2.8K | +21.7% ▲ | |
| Finerenone | 13 | 364 | £453 | +19.5% ▲ |
| Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | 13 | 364 | £168 | -20.5% ▼ |
| Olmesartan medoxomil | 13 | 476 | £20 | -81.1% ▼ |
| Prasugrel | 13 | 392 | £54 | -58.6% ▼ |
| Doxylamine succinate/pyridoxine hydrochloride | 13 | 386 | £551 | +17.8% ▲ |
| Rifampicin | 13 | 1,260 | £316 | +126.8% ▲ |
| Exenatide | 13 | 52 | £954 | -25.9% ▼ |
| Tablets OTC glucose for diabetic hypo treatment (0913541) | 13 | 410 | £33 | -13.5% ▼ |
| Tube feed 1 kcal/ml with fibre, higher protein (0914011) | 13 | 390.0K | £6.7K | +43.3% ▲ |
| Gentamicin sulfate | 13 | 130 | £247 | +136.6% ▲ |
| Loteprednol etabonate | 13 | 65 | £68 | +40.6% ▲ |
| Pilocarpine hydrochloride | 13 | 130 | £416 | +26.6% ▲ |
| Alkyl sulphate | 13 | 3,068 | £81 | +40.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.